What is the role of in the treatment of middle cerebral artery (MCA) stroke?

Updated: Mar 17, 2020
  • Author: Daniel I Slater, MD; Chief Editor: Stephen Kishner, MD, MHA  more...
  • Print


HMG-CoA reductase inhibitors, or statins, have been shown to decrease the 10-year risk for recurrent stroke. [84] The individual agent should be selected based on potency needed, drug-statin interactions, and tolerability. Statin potency from lowest to highest based on the maximum dose is fluvastatin, pravastatin, lovastatin, simvastatin, atorvastatin, and rosuvastatin. [85]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!